Bivalirudin Versus Heparin in Patients with or Without Bail-out GPI Use: a Pre-Specified Subgroup Analysis from the BRIGHT-4 Trial
BMC MEDICINE(2024)
Key words
BRIGHT-4,Glycoprotein IIb/IIIa inhibitors,Bivalirudin plus high-dose infusion,Heparin,Procedural thrombotic complications
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined